Summary
Topical glucocorticosteroids are useful in the treatment of various skin diseases. Although many corticosteroids are available today, there is still a need for highly potent compounds with minimal adverse effects.
Methylprednisolone aceponate (MPA) has recently been synthesized. Its activity has been evaluated using the vasoconstrictor assay and the poison ivy test (rhus dermatitis) in 19/20 healthy volunteers of either sex. Comparable blanching was found with MPA in a cream vehicle, in an ointment and a fatty ointment.
Vasoconstriction and suppression of experimentallyinduced poison ivy contact dermatitis were dose-dependent in the concentration range 0.01% to 0.5% MPA. Concentrations of MPA of at least 0.05% were significantly active. Following the highest dose, blanching was close to the maximum which can be obtained.
This finding, and the improvement of rhus dermatitis, suggest that MPA belongs to the highly potent local glucocorticosteroids.
Similar content being viewed by others
References
Robertson DB, Maibach HI (1983) Topical Corticosteroids. Sem Dermatol 2: 238–249
Stoughton RB, Cornell RC (1988) Topical corticosteroids in dermatology. In: Christophers E, Schöpf E, Kligman AM, Stoughton RB (eds) Topical corticosteroid therapy. A novel approach to safer drugs. Raven, New York, pp 1–12
Stoughton RB, Cornell RC (1987) Review of super-potent topical corticosteroids. Sem Dermatol 6: 72–76
Bodor N (1988) The application of the soft drug approaches to the design of safer corticosteroids. In: Christophers E, Schöpf E, Kligman AM, Stoughton RB (eds) Topical corticosteroid therapy. a novel approach of safer drugs. Raven, New York, pp 13–25
Stevanovic DV, Wilson L, Sparkes CG (1977) A separation of clinical from epidermal thinning effect in the topical glucocorticoid clobetasone butyrate. Br J Dermatol 96: 67–70
McKenzie AW, Stoughton RB (1962) Method for comparing percutaneous absorption of steroids. Arch Dermatol 86: 608–610
McKenzie AW (1962) Percutaneous absorption of steroids. Arch Dermatol 86: 611–614
Kaidbey KH, Kligman AM (1976) Assay of topical corticosteroids. Arch Dermatol 112: 808–810
Cornell RC, Stoughton RB (1985) Correlation of the vasoconstrictor assay and clinical activity in psoriasis. Arch Dermatol 121: 63–67
Barry BW, Woodford R (1976) Proprietary hydrocortisone creams. Vasoconstrictor activities and bio-availabilities of six preparations. Br J Dermatol 95: 423–425
Barry BW, Woodford R (1974) Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels. Br J Dermatol 91: 323–338
Wilson L (1976) The clinical assessment of topical corticosteroid activity. Br J Dermatol 94 (Suppl 12): 33–42
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kecskés, A., Jahn, P., Wendt, H. et al. Dose-response relationship of topically applied methylprednisolone aceponate (MPA) in healthy volunteers. Eur J Clin Pharmacol 43, 157–159 (1992). https://doi.org/10.1007/BF01740663
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01740663